Prescribers provided insufficient water to patients with hyperosmolar dehydration [77–79], failed to anticipate falls in serum potassium in fasting diabetic patients on insulin infusions [80], and prescribed volume-expanding fluids for patients with a diagnosis of heart failure on admission [81]. The gene discussed is INS; the disease is heart failure.